Author | Alexander M. M. Eggermont, MD, PhD | OncLive

Author | Alexander M. M. Eggermont, MD, PhD

Articles

Dr. Eggermont on Responses to Adjuvant Pembrolizumab in Stage III Melanoma Subtypes

July 09, 2020

Video

Alexander M. M. Eggermont, MD, PhD, discusses responses to adjuvant pembrolizumab in patients with different subtypes of stage III melanoma.

Dr. Eggermont Discusses Impact of Pembrolizumab in Melanoma

September 24, 2018

Video

Alexander M. M. Eggermont, MD, PhD, director general of Gustave Roussy Cancer Campus Grand Paris in Villejuif, France, discusses the impact of pembrolizumab in melanoma.

Dr. Eggermont on the Impact of Adjuvant Anti-PD-L1 Agents in Melanoma

April 18, 2018

Video

Alexander M. M. Eggermont, MD, PhD, director general of Gustave Roussy Cancer Campus Grand Paris in Villejuif, France, discusses the impact of adjuvant anti–PD-L1 agents on the treatment landscape of melanoma.

x